Clinical Trial: Correlation of HER2 Status with 21-Gene Recurrence Score and Biomarker Exploration in HR+/HER2- Early Breast Cancer: A Single-Center Retrospective Cohort Study (China)

Posted On: 2026-10-26

China, Oct. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Correlation of HER2 Status with 21-Gene Recurrence Score and Biomarker Exploration in HR+/HER2- Early Breast Cancer: A Single-Center Retrospective Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135060

Registration Time: 2026/10/23

Type: Observational study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348546

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Correlation of HER2 Status with 21-Gene Recurrence Score and Biomarker Exploration in HR+/HER2- Early Breast Cancer: A Single-Center Retrospective Cohort Study (China)